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Abstract  24 
To increase the intestinal delivery of dietary β-carotene, there is a need to develop 25 
nanostructured food systems to encapsulate this fat soluble bioactive. The aim of this study was 26 
to evaluate the bioacessibility and bioavailability across the intestinal barrier of β-carotene-27 
enriched nanoemulsions stabilised with two emulsifiers (lecithin or sodium caseinate) by 28 
coupling an in vitro gastrointestinal digestion with two in vitro cell culture models (Caco-2 or co-29 
culture of Caco-2/HT29-MTX). Nanoemulsions stabilised with lecithin had significantly higher β-30 
carotene in the gastrointestinal digested micellar fraction, lower β-carotene in the Caco-2 (and 31 
Caco-2/HT29-MTX) apical compartment and significantly higher β-carotene in Caco-2 cellular 32 
content compared to β-carotene-enriched nanoemulsions stabilised with sodium caseinate. 33 
Finally, to assess anti-inflammatory activity of digested nanoemulsions, lipopolysaccharide 34 
stimulated macrophages were exposed to Caco- 2 basolateral samples with levels of TNF-α 35 
and IL-β, subsequently quantified. A TNF-α response from stimulated THP-1 macrophages was 36 
elicited by basolateral samples, regardless the emulsifier used to formulate nanoemulsions. 37 
This study demonstrated that β-carotene permeability is influenced by the food derived 38 
emulsifier used for stabilising nanoemulsions, indicating that composition may be a critical factor 39 
for β-carotene delivery. 40 
 41 
















1. Introduction 49 
β-carotene is a vitamin A precursor with poor water-solubility (0.0006 g/L at 25ºC). Positive 50 
health benefits associated with β-carotene consumption include lower incidence of cancer, 51 
cardiovascular diseases and degenerative disorders (Goralcyk, 2009). These health attributes 52 
have been related to β-carotene’s antioxidant and immunomodulatory bioactivities, proven both 53 
in vitro (Bai et al., 2005) and in vivo (Zhou et al., 2018).  54 
Although the recommended dietary allowance (RDA) for β-carotene has not been set, the U.S. 55 
Food and Drug Administration and the European Food Safety Authority derive a RDA for 56 
vitamin A of 900-700 µg of retinol activity equivalents (RAE) daily and a population reference 57 
intake of 750-650 µg REA daily, respectively. In addition, β-carotene appears to be degraded by 58 
the acidic environment of the stomach (Boon, McClements, Weiss, & Decker, 2010) which 59 
undoubtedly reduces β-carotene concentration in the intestine. 60 
As a solution, recent studies have revealed the use of nanostructured delivery systems such as 61 
nanoemulsions to encapsulate and protect β-carotene after oral consumption and enhance its 62 
delivery to intestinal barrier (Chen, Li, Li, McClements, & Xiao, 2017; Gasa-Falcon et al., 2020; 63 
Yi, Zhong, Zhang, Yokoyama, & Zhao, 2015). Β-carotene enriched nanoemulsions stabilised 64 
with pectin, lecithin, sodium caseinate, Tween 20 or sucrose palmitate, have been subjected to 65 
in vitro gastrointestinal digestion (GID) and the subsequent release of β-carotene has been 66 
determined (Gasa-Falcon et al., 2019; Salvia-Trujillo et al., 2013; Teixé-Roig et al., 2020). 67 
However, less information is currently available about the use of either proteins or 68 
phospholipids-based emulsifiers on β-carotene transit across the intestinal barrier and 69 
subsequent bioactivity from nanoemulsions post gastrointestinal digestion (GID). For instance, 70 
Lu, Kelly, & Miao (2017) described that the permeability of β-carotene in undifferentiated naïve 71 
gastrointestinal epithelial cells is depended on the emulsifier type added to the nanoemulsions 72 
rather than initial particle size of the nanoemulsions.  73 
To model absorption in vitro, the use of differentiated monolayers expressing tight junctions, 74 
best represent the morpho-functional features of the intestinal barrier (Guri, Gülseren, & 75 
Corredig, 2013). However, in vitro monolayers present their own challenges since digestive 76 










concentrations (Arranz, Corredig, & Guri, 2016). As a result, quantification of compounds on the 78 
basolateral side can be challenging.  79 
Thus, the aim of this study was to evaluate the permeability of β-carotene-enriched 80 
nanoemulsions stabilised with two different emulsifiers across 21 days differentiated Caco-2 81 
and Caco-2/HT29-MTX co-cultures, post in vitro static GID. These 21 days old Caco-2/HT29-82 
MTX co-cultures best represent the mature intestinal mucus barrier. Emulsifiers (lecithin and 83 
sodium caseinate) were selected based on their different properties (low (758 g/mol) and high 84 
(≈10-50 KDa) molecular weight), sources (synthetic and natural) and previous physiochemical 85 
characterisation of nanoemulsions stabilised with these emulsifiers in our group (Gasa-Falcon 86 
et al., 2019). Furthermore, the subsequent basolateral anti-inflammatory activity was assessed 87 
by quantification of TNF-α and IL-β in lipopolysaccharide (LPS) stimulated macrophages (THP-1 88 
cells). 89 
 90 
2. Materials and methods 91 
2.1. Materials 92 
Corn oil (Mazola, ACH Food Companies Inc., Memphis, TN) was purchased from a local 93 
market. β-carotene (synthetic, ≥93% (UV), powder) was sourced from Sigma–Aldrich (Ireland). 94 
Lecithin was obtained from Alfa Aesar (Karlsruhe, Germany). Sodium caseinate (NaCas) (≥92% 95 
purity) was from Acros Organics (Geel, Belgium). The Caco-2 cell line was purchased from the 96 
European Collection of Cell Cultures (ECACC 86010202) and the human monocyte THP-1 97 
(ATCCTIB-202) and the human colon adenocarcinoma HT-29 cell lines (ATCCHTB-38) were 98 
purchased from American Type Culture Collection. This latter cell line was differentiated to HT-99 
29-MTX following the protocol described by Guri et al. (2013). Tissue culture plastics were 100 
sourced from Sarstedt Ltd. (Wexford, Ireland). CellTiter 96 AQueus One Solution reagent was 101 
purchased from Promega (MyBio, Kilkenny, Ireland). Milli-Q water was used to prepare all 102 
nanoemulsions. All other chemicals were sourced from Sigma–Aldrich (Ireland) unless specified 103 
otherwise. 104 
 105 










Primary emulsions were prepared by mixing 4% (w/w) of the lipid phase (corn oil enriched with 107 
0.5% w/w of β-carotene) with 96% (w/w) of the aqueous phase containing the emulsifier (lecithin 108 
or NaCas) at 2% (w/w). Both phases were mixed with an Ultra-Turrax (IKA, Staufen, Germany) 109 
at 9500 rpm for 3 minutes. Then, primary emulsions were passed through an APV 1000 (SPX 110 
Flow Technology, Charlotte, NC, USA) at 500 bars for 3 cycles to obtain nanoemulsions. 111 
 112 
2.3. Determination of nanoemulsions 113 
properties 114 
Particle size of nanoemulsions was determined using a Mastersizer 3000 (Malvern Instruments 115 
Ltd, Worcestershire, UK). The results were reported as the surface mean diameter (d43 (µm)) 116 
and the width of the distribution. The refractive index of the corn oil and water employed to 117 
perform the analysis were 1.34 and 1.33, respectively.  118 
The emulsions ζ-potential was determined using a Zetasizer NanoZS (Malvern Instruments Ltd, 119 
Worcerstershire, UK). Samples were previously diluted (1/100) and equilibrated prior to 120 
analysis. 121 
Physical stability of β-carotene enriched nanoemulsions was determined with an analytical 122 
centrifuge LUMiSizer 6112 (L.U.M. GmbH, Berlin, Germany) that accelerates destabilisation of 123 
samples. Results were analysed using the software package SEPView 6.0 (L.U.M. GMBH) that 124 
records transmitted light across the sample length and calculates the instability index that 125 
ranges from 0 to 1, with the greatest instability at 1. Instrumental parameters used for physical 126 
stability analysis were: speed 2,186 rcf; time interval 20 seconds; exposure time 10,000 127 
seconds; temperature 25ºC. 128 
 129 
2.4. In vitro static simulated digestion 130 
Nanoemulsions were subjected to a simulated in vitro static GID (gastric and upper intestinal 131 
phases) that mimics the adult human upper gut. The INFOGEST standardised method 132 
(Brodkorb et al., 2019) was followed with minor modifications. Briefly, gastric phase consisted of 133 
5 mL of nanoemulsion with simulated gastric fluid containing porcine pepsin (EC 3.4.23.1) 134 
(3925.3 U/mg); pH was adjusted to 3.0 using HCl (1 M) and volume to 10 mL (Milli-Q water). 135 










was increased to 6.5 using NaOH and 20 µL CaCl2 (0.3 M), 4 ml bile (630 g/mol, EC232-369-0), 137 
and 2.5 mL pancreatin based on trypsin activity (8.13 U/mg; EC232.468.9) were added. Based 138 
on Verkempinck et al. (2017), extra lipase (pancreatin and lipase) was added to reach 420 139 
U/mL. The pH of the mixture was adjusted to 7.0, the volume to 20 mL with milli-Q water, and 140 
the mixture was incubated for 2 h at 37°C. The digestion was then stopped by adding protease 141 
inhibitor 4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride (1 mM). To obtain the micellar 142 
fraction, the digested fractions were centrifuged (Heraeus Megafuge 1.0, Massachusetts, USA) 143 
at 2890 x g for 40 minutes at 4 °C (Garrett, Failla, Sarama, &Craft, 1999). Samples were stored 144 
at −80°C for further experiments.  145 
 146 
2.5. In vitro cell based assays 147 
Caco-2 and HT29-MTX cell lines were grown in 75 cm2 tissue culture flasks in a humidified 37 148 
°C incubator with a 5% CO2 air atmosphere. Cells were cultured in Dulbecco’s modified Eagle's 149 
medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 100 U/mL penicillin, 150 
and 100 mg/mL streptomycin. At 80% confluency, cells were trypsinated (0.25% trypsin/EDTA), 151 
diluted 1:6 in DMEM medium, and reseeded in flasks. Caco-2 and HT29-MTX cell lines in this 152 
study were used at passage number 29-41 and 53-67, respectively. 153 
 154 
2.6. Cytotoxicity of micellar fractions 155 
Caco-2 cells were seeded at a density of 8 × 104 cells/well in 96-well plate. After 24 h of 156 
incubation, cells were washed with PBS. GID micellar fractions were filtrated (0.45 µm), diluted 157 
in complete DMEM (between 2-16% v/v) and 80 µL were added to each well. Subsequently, 20 158 
μL of CellTiter 96® AQueous One Solution Cell Proliferation Assay reagent was added to each 159 
well and cells were incubated for 2 h. After 2 h, the quantity of formazan produced was 160 
measured spectrophotometrically at 490 nm in a microplate reader (Synergy HT BioTek, 161 
Winooski, VT, USA). Results were expressed as the percentage of cellular viability relative to a 162 
control group (cells with DMEM medium) versus the micellar fraction concentration (%, v/v). 163 











2.7. Permeability across intestinal barriers  166 
Caco-2 cells were seeded at a density of 6 × 104 cells per insert in 12-well Transwell® plates 167 
(0.4 μm pore size, 1.2 cm diameter, Costar, Cambridge, MA). In co-culture experiments, Caco-2 168 
and HT29-MTX were grown separately and then seeded at a ratio of 75:25, to a final density 6 × 169 
104 cells per insert.  170 
Culture media of each plate was changed every two days for 21 days. The integrity of the cell 171 
monolayer was monitored by measuring the transepithelial electrical resistance (TEER) (Ω·cm2) 172 
using a Millicell-ERS Voltohmmeter (Merck Millipore, Carrigtwohill, County Cork, Ireland). On 173 
day 21, apical and basolateral compartments were washed three times with PBS and 470.6 µL 174 
and 1500 µL DMEM were added to apical and basolateral compartments, respectively. Then, 175 
micellar fractions (29.4 µL) were added to apical compartment and incubated for 2 h. During this 176 
2 h, the TEER value did not change significantly (data not shown). 177 
After permeability experiment, apical and basolateral samples were collected. Moreover, cell 178 
monolayer was washed three times with PBS, scraped and collected. Cells were centrifuged 179 
(Heraeus Megafuge 1.0) for 3 min at 215 x g and the supernatant discarded. Cells were stored 180 
at -80 ºC for further analysis.  181 
 182 
2.8. Determination of β-carotene 183 
Extraction of β-carotene from samples (apical, cells and basolateral) was performed as 184 
described by Yuan, Gao, Zhao, & Mao (2008) with minor modifications. Briefly, the samples 185 
were filtrated (0.45 µm) and mixed with ethanol and hexane, followed by a centrifugation (2890 186 
x g, 5 min, 5ºC) (Heraeus Megafuge 1.0). The upper fraction was collected, dried under N2 and 187 
stored at -80 ºC. Each sample extract was dissolved in 200 µL of the injection solvent 188 
acetonitrile (ACN): methanol (MeOH) 7:3 (v/v): acetone 6.7:3.3 (v/v) and filtered through 0.2 µm 189 
nylon filters (Millipore, Bedford, MA). High-performance liquid chromatography system (Waters 190 
Xevo TQ-S, Milford, USA) equipped with a photodiode array detector (HPLC-PDA) at 450 nm 191 
and a column ACQUITY UPLC® (C18 BEH 130 Å, 1.7 µm, 2.1 × 150 mm) (Waters) (30°C and 192 
flow rate 0.85 mL/min) were used. . Mobile phase consisted of solvent A: ACN: MeOH 7:3 (v/v) 193 










quantified by comparison with external standards. Results were reported as ng/mL and cellular 195 
uptake as percentage of detected β-carotene in cells versus apical samples at time 0 h.  196 
 197 
2.9. Anti-inflammatory activity of basolateral 198 
samples 199 
Human monocytes THP-1 were cultured in RPMI 1640 culture medium supplemented with 10% 200 
(v/v) FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin at 37 °C in a 5% CO2 humidified 201 
atmosphere. Cells were added at a density of 5 x 105 cells/mL in 24 well plates. Differentiation 202 
to macrophages was induced by adding 1 µg/µL 12-O-tetradecanoyl phorbol-13-acetate (TPA) 203 
to cells followed by 48 h incubation. After differentiation to macrophages, cells were washed 204 
with PBS. LPS (0.05 µg/mL) and Caco-2 basolateral samples were added to each well. After 24 205 
h incubation, the culture medium was collected for subsequent TNF-α and IL-1β quantification.  206 
Release of TNF-α and IL-1β was measured in the supernatants of THP-1 cells using ELISA kits 207 
(R&D Systems, Minneapolis, USA), according to manufacturer’s instructions. Multiscanner 208 
autoreader (Synergy HT BioTek) was used to read the absorbance of the plates at 450 nm.  209 
 210 
2.10. Statistical analysis 211 
Experiments were performed in triplicate on at least two different days and data was expressed 212 
as the mean with standard deviation. To determine the statistically significant differences 213 
between samples, one-way ANOVA followed by Bonferroni test (p≤0.05) was conducted with 214 
SigmaPlot 11.0. 215 
 216 
3. Results and discussion 217 
3.1. Physicochemical properties of nanoemulsions 218 
Both nanoemulsions containing lecithin and NaCas had a monomodal particle size distribution 219 
(Fig. 1A) and exhibited particle sizes in the nanometer range (0.35 and 0.29 µm, respectively) 220 
(Table 1), in line with our previous published results (Gasa-Falcon et al., 2019). Nanoemulsions 221 










NaCas-stabilised nanoemulsions exhibited the lowest end point instability index (0.603 ± 0.006) 223 
compared with lecithin-stabilised nanoemulsions (0.773 ± 0.001) (Fig. 1B). 224 
Emulsifiers with a low molecular weight and/or with a high hydrophilic–lipophilic balance (HLB) 225 
are associated with a high efficiency at producing small particle sizes in oil-in-water emulsions 226 
(Jo & Kwon, 2014). Lecithin has an HLB value of 8 while NaCas has a value of 14. Thus, the 227 
intermediate-low HLB value of lecithin could explain why nanoemulsions stabilised with this 228 
emulsifier exhibited the highest particle size and instability index compared to nanoemulsions 229 
with NaCas (Iyer et al., 2015). In addition, the mass of NaCas (≈10-50 KDa) (Ozturk & 230 
McClements, 2016), its gelation behaviour (Rodriguez-Patino & Pilosof, 2011) and the thick 231 
interfacial layer covering oil droplets (McClements et al., 1993) undoubtedly contributed to its 232 
nanoemulsion stability over the accelerated centrifugation process. The large negative ζ-233 
potential values observed for lecithin and NaCas nanoemulsions (-58.81 mV and -53.41 mV, 234 
respectively) could be attributed to the phospholipid head groups from lecithin, and the fact that 235 
the nanoemulsion pH of ≈6.5 differs to the NaCas isoelectric point (pI=4.6) respectively (Chang 236 
& McClements, 2016). Interestingly, ζ-potential of lecithin stabilised β-carotene nanoemulsions 237 
became less negative after in vitro GID, while NaCas emulsions post GID have a stronger 238 
negative value (Gasa-Falcon et al., 2019). In that previous study, particle size after in vitro GID 239 
in lecithin nanoemulsions was higher compared to NaCas. 240 
 241 
3.2. Cytotoxicity of micellar fractions 242 
The maximum non-toxic concentration of micellar fractions was different depending on the 243 
emulsifier used (Fig. 2). Micellar fractions with lecithin showed no cell toxicity (>90% cell 244 
viability) when Caco-2 cells were exposed to concentrations below 6% (v/v) (Fig. 2A), while for 245 
those containing NaCas no cell toxicity was observed at concentrations under 10% (v/v) (Fig. 246 
2B). 247 
In agreement to our results, several studies have demonstrated that emulsifiers are cytotoxic in 248 
a concentration-dependent manner and that toxicity of nanoemulsions depends on the nature of 249 
emulsifier employed (Buyukozturk, Benneyan, & Carrier, 2010; Ujhelyi et al., 2012). 250 
Furthermore, Sadhukha, Layek & Prabha (2018) observed that the aqueous fraction of digested 251 










viability by 40%. It has been previously reported that monoglycerides induce dose-dependent 253 
apoptosis in mammalian cells (murine thymocytes), which consisted on a rapid reduction in 254 
mitochondrial transmembrane potential, production of reactive oxygen species, among other 255 
processes (Philippoussos, Arguin, Fortin, Steff, & Hugo, 2002). In our study, micellar factions of 256 
nanoemulsions were likely to contain lipid digestion products (i.e. free fatty acids and 257 
monoglycerides), and together with emulsifiers contributed to damage the cell integrity. 258 
Similar cell viability results were obtained when control micellar fractions (without β-carotene) 259 
were tested in Caco-2 cells, but interestingly control micellar fractions derived from lecithin- 260 
stabilised nanoemulsions were 60% less toxic compared to micellar fractions with β-carotene. 261 
This suggests that β-carotene plays a role in cell cytotoxicity of Caco-2 monolayers. Indeed, 262 
Wooster et al. (2017) observed that the presence of β-carotene in LCT nanoemulsions (IC50= 51 263 
µg/mL) increased four times their toxicity in differentiated Caco-2 cells compared to empty 264 
nanoemulsions (IC50= 257 µg/mL). In contrast, a preliminary study by our laboratory indicated 265 
that pure β-carotene present in nanoemulsions was not cytotoxic to undifferentiated Caco-2 266 
cells (between 0.05 µg/mL and 10 µg/mL) (data not shown), suggesting that Caco-2 cell 267 
monolayers with tight junctions are more sensitive to GID β-carotene-enriched nanoemulsions 268 
than undifferentiated Caco-2 cells. Certainly, oxidation products of β-carotene could have been 269 
generated during in vitro GID, specifically due to the acidic pH of the gastric phase (Failla, 270 
Chitchumronchokchai, Ferruzzi, Goltz, & Campbell, 2014). Oxidation of β-carotene can produce 271 
carotenoid aldehyde breakdown products, which have documented toxic effects on numerous 272 
cell lines (K562, RPE 28 SV4 and ARPE-19) at concentrations between 10–20 µM (Hurst, Saini, 273 
Jin, Awasthi, & Van Kuijk, 2005).  274 
To investigate the bioavailability of β-carotene from nanoemulsions, permeability experiments 275 
were performed with lecithin and NaCas micellar fractions at a concentration of 6% (v/v).  276 
 277 
3.3. Permeability of β-carotene nanoemulsions  278 
After in vitro GID, β-carotene concentration present in the micellar fractions was significantly 279 
higher in lecithin nanoemulsions compared to those prepared with NaCas (Table 2). There was 280 
a significant reduction of β-carotene in apical compartment after 2 h incubation compared to 281 









stabilised nanoemulsions had a significantly higher amount of β-carotene compared to lecithin-283 
stabilised nanoemulsions. β-carotene content in cell lysates of Caco-2 cells was 3 times higher 284 
than in Caco-2/HT29-MTX co-cultures. In addition, the β-carotene concentration in Caco-2 cells 285 
lysates was significantly higher in lecithin-stabilised nanoemulsions (2.28%) compared with 286 
nanoemulsions containing NaCas (1.72%). Concentration of β-carotene was significantly lower 287 
in Caco-2/HT29-MTX co-cultures cell lysates (≥0.74%), with no significant differences between 288 
both emulsifiers. 289 
The reason why NaCas nanoemulsions had less β-carotene in the micellar fraction, the apical 290 
sample at time zero and the cell lysate (Caco-2) may be explained by the fact that proteins such 291 
as NaCas, can interact hydrophobically with carotenoids and create complexes that act as a 292 
physical barrier for gastrointestinal digestive enzymes access (Wackerbarth, Stoll,  Gebken, 293 
Pelters, & Bindrich, 2009). Hence, β-carotene may have remained entrapped within these 294 
complexes and not solubilised within mixed micelles, a process which is essential for 295 
permeability across the intestinal barrier (Baskaran, Sugawara, & Nagao, 2003). Moreover, 296 
Yang, Decker, Xiao, & McClements (2015) observed that the addition of 36 mg phospholipids 297 
(eg. 1,2-Dioleoyl-sn-glycero-3-phosphocholine) within the digestive fluids increased the degree 298 
of lipid digestion after in vitro GID of vitamin E emulsions. This may explain why lecithin-299 
nanoemulsions had higher concentrations of β-carotene within the micellar fraction. Another 300 
study observed that the maximum cellular uptake of carotenoids (β-carotene and lutein) in 301 
differentiated Caco-2 cells was obtained when micelles contained 50 µmol/L of 302 
lysophosphatidylcholine (phospholipid derived from phosphatidylcholine present in lecithin) 303 
(Sugawara et al., 2001).  304 
In agreement with the present study, Li. Arranz, Guri & Corredig (2017) reported a lower 305 
permeability of β-carotene from liposomes using 21-day old Caco-2/HT29-MTX co-cultures 306 
compared to Caco-2 monolayers. Interaction with mucus produced by HT29-MTX cell line 307 
reduces permeability of mucoadhesive lipophilic molecules, such as β-carotene (Sigurdsson, 308 
Kirch, & Lehr, 2013). Co-culturing Caco-2 cells with HT-29MTX adds a further layer of mucus 309 
complexity to more closely resemble the in vivo environment (Arranz. Corredig & Guri, 2016), 310 










use of Caco-2/HT29-MTX cell line resulted in lower recovery of β-carotene in the cell lysates 312 
regardless of the emulsifier. 313 
The failure to detect β-carotene in basolateral compartment underlined the limitations of the 314 
experiment due to upper concentration limits imposed by cytotoxicity data and inadequate 315 
sensitivity of detection instrumentation. Also, β-carotene may not have arrived at the basolateral 316 
within the 2 h incubation period.  317 
 318 
3.4. Immune functionality of basolateral samples 319 
Basolateral samples from permeability assays with β-carotene NaCas nanoemulsions and β-320 
carotene lecithin nanoemulsions significantly increased TNF-α secretion (112% and 124% 321 
respectively, p<0.05) compared to basolateral sample control (positive control =2291±138 322 
pg/mL of TNF-α) from LPS activated THP-1 macrophages (Fig. 3A). However, IL-1β levels were 323 
unchanged regardless of basolateral samples (4769±145 pg/mL) (Fig. 3B).  324 
Previous studies have demonstrated that β-carotene reduces levels of TNF-α and IL-1β levels 325 
secreted from LPS-stimulated RAW264.7 cells (murine macrophage cell line) and from LPS-326 
treated peritoneal macrophages (Li, Hong, & Zheng, 2019) as well as from serum of BALB/c 327 
mice, intraperitoneally injected with β-carotene (10 mg/kg) plus LPS (4 mg/kg) (Bai et al., 2005). 328 
This discrepancy with our results may be explained by the bypass of the gut and the use of 329 
different test material (β-carotene alone versus basolateral samples of Caco-2 monolayers 330 
treated with β-carotene-enriched nanoemulsions). Applying β-carotene directly to LPS 331 
stimulated THP-1 cells will dose dependently reduce secreted levels of TNF-α (data not shown). 332 
It is important to note that our results do not confirm the presence of β-carotene or metabolites 333 
in the basolateral compartment. It is possible that other GID components in the micellar fraction 334 
may be capable of modulating TNF-α, although previous studies have shown that lecithin, 335 
sodium caseinate or emulsions with different fatty acid composition do not up-regulate cytokine 336 
production (Mukhopadhya et al., 2014, Reimund et al., 2004, Treede et al., 2009). However, β-337 
carotene can be metabolised to high molecular weight products (β-apo-8’-carotenal, β-apo-10’-338 
carotenal, β-apo-12’-carotenal, β-apo-14’-carotenal, β-apo-15’-carotenal) and short-chain 339 










ionone) (Siems et al., 2005), which themselves may directly or indirectly act as pro-inflammatory 341 
agents (Yeh, Wang, Chen, & Wu, 2009). 342 
 343 
4. Conclusions 344 
Bioaccessibility of GID β-carotene in a Caco-2 model was enhanced when β-carotene-enriched 345 
nanoemulsions were stabilised with lecithin compared to those stabilised with NaCas. Caco-2 346 
basolateral samples from both nanoemulsions elicited a TNF-α response from stimulated THP-1 347 
macrophages. This study elucidates the importance of nanoemulsion composition for in vitro 348 
cellular permeability assays and the hurdles faced by concentration limits. Nanostructured food 349 
systems using lecithin as emulsifier might be a potential tool to increase uptake of dietary β-350 
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Table 1. Particle size (µm) and ζ-potential (mV) of nanoemulsions stabilised with different 
emulsifiers (LE: lecithin; NaCas: sodium caseinate). Differences among nanoemulsions were 
compared using one-way ANOVA followed by Bonferroni test. Different letters indicate 
statistically significant differences within the parameter tested (p<0.05). 
 
Table 2. β-carotene concentration (ng/mL) quantified by high-performance liquid 
chromatography (HPLC-PDA) in micellar fractions (after in vitro digestion), apical samples and 
basolateral samples from permeability experiments after 2h incubation with micellar fractions 
obtained after in vitro digestion of nanoemulsions stabilised with lecithin (LE) and sodium 
caseinate (NaCas). ND = not detected, i.e., below detection limit of 10 ng/ml. Within a row, 
different lowercase letters indicate statistically significant differences (p<0.05) between 
emulsifiers. For an emulsifier, a statistical difference between apical t=0 and apical t=2h is 
denoted by *. Statistical analysis was performed using one-way ANOVA followed by Bonferroni 
test (*p<0.05). 
Fig 1. (A) Particle size distribution and (B) instability profile of β-carotene-enriched 
nanoemulsions (0.02% β-carotene w/w, 4% corn oil w/w) stabilised with 2% of lecithin (LE) or  
NaCas: sodium caseinate (NaCas). 
Fig 2. Cell viability (%) of Caco-2 cells after 2h incubation with micellar fractions (with β-
carotene) (% v/v) and control micellar fractions (without β-carotene) (% v/v) obtained after in 
vitro digestion of nanoemulsions stabilised with different emulsifiers. Micellar fractions 
containing lecithin (A) and NaCas (B) were diluted with complete DMEM. Control cells (Ctrl) 
were grown in media with no treatment (100% viability). Different uppercase and lowercase 
letters indicate significant differences to control cells for micellar fractions and control micellar 
fractions, respectively. Statistical analysis was performed using one-way ANOVA followed by 











Fig 3. Effects of basolateral samples resulted from permeability experiments with β-carotene-
enriched nanoemulsions emulsified with either 2% sodium caseinate (NaCas+) or lecithin (LE+) 
on the secretion (% ± SEM) of TNF-α (A) and IL-1β (B) in lipopolysaccharide (LPS)-simulated 
THP-1 cells. Positive controls (Ctrl +) were LPS-stimulated THP-1 cells and negative controls 
(Ctrl -) were non-stimulated THP-1 cells. Both controls were incubated with basolateral samples 
collected from control Caco-2 monolayers. Different letters indicate significant differences. 









Table 1.  1 
Emulsifier Particle size (µm) ζ-potential (mV) 
LE 0.35 ± 0.001a -58.81 ± 2.56a 
NaCas 0.29 ± 0.001b -53.41 ± 1.83b 
 2 
 3 








Table 2.  
 
 Caco-2 model (ng/mL) Caco-2/HT29-MTX model (ng/mL) 
Emulsifier LE NaCas LE NaCas 
Micellar fraction  
36430 ± 665
a
 32858 ± 70
b
 37370 ± 521
a






 1930 ± 4
b*
 2198 ± 40
a*






 339 ± 65
b
 263 ± 36
a






 33.2 ± 8.4
b
 15.1 ± 5.7
c
 18.1 ± 11.2
c
 





















































Micellar fraction concentration (% v/v)
Ct



































Micellar fraction concentration (% v/v)
Ct
































































































- Permeability of β-carotene was assessed using in vitro cell culture models. 
- Bioaccessibility of β-carotene was enhanced with lecithin-stabilised nanoemulsions 
- Nanoemulsions elicited a TNF-α response from stimulated THP-1 macrophages 
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